Published October 20, 1993 | Version v1
Report Open

Accelerator mass spectrometry in biomedical research

Description

Biological effects occur in natural systems at chemical concentrations of parts per billion (1:109) or less. Affected biomolecules may be separable in only milligram or microgram quantities. Quantification at attomole sensitivity is needed to study these interactions. AMS measures isotope concentrations to parts per 1013--15 on milligram-sized samples and is ideal for quantifying long-lived radioisotopic labels that are commonly used to trace biochemical pathways in natural systems. 14C-AMS has now been coupled to a variety of organic separation and definition technologies. The primary research investigates pharmacokinetics and genotoxicities of toxins and drugs at very low doses. Human subject research using AMS includes nutrition, toxicity and elemental balance studies. 3 H, 41Ca and 26Al are also traced by AMS for fundamental biochemical kinetic research. Expansion of biomedical AMS awaits further development of biochemical and accelerator technologies designed specifically for these applications

Availability note (English)

MF available from INIS under the Report Number; Also available from OSTI as DE94004336; NTIS; US Govt. Printing Office Dep.

Files

25033670.pdf

Files (1.7 MB)

Name Size Download all
md5:4435c158cb2b4b4c85b757f23f078e98
1.7 MB Preview Download

Additional details

Publishing Information

Imprint Pagination
24 p.
Report number
UCRL-JC--113838

Conference

Title
6. international conference on accelerator mass spectrometry.
Dates
17 Sep - 1 Oct 1993.
Place
Canberra (Australia).

Optional Information

Contract/Grant/Project number
Contract W-7405-ENG-48
Funding organization
USDOE, Washington, DC (United States).
Secondary number(s)
CONF-930960--4.